Objective: To evaluate the clinical therapeutic effect of the combination of Wenglitong capsule and western medicine in the treatment of benign prostatic hyperplasia. Method: Fifty two cases of control group treated by western medicine

48 cases of treatment group treated by the combination of Wenglitong capsule and western medicine

international prostate symptom sore(IPSS)

quality of life(QOL)

maximum flow rate (MFR)

volume(V)

white blood cell(WBC) were compared between two groups in the pre-theatment and had been theated 12 weeks. Rusult: IPSS

QOL

MFR

WBC of two groups presented siginificant statistical difference in comparison. Treatment group superior to control group. The total effective was 94% in treatment group

the total effective was 85% in control group. There were no difference on V. Conclusion: The combination of Wenglitong capsule and western medicine in the treatment of benign prostatic hyperplasia can improve more obviously impacts and quaulity of life than by western medicine only.